Hepatitis C DNA vaccine - Merck & Co.Alternative Names: HCV DNA vaccine - Merck & Co.
Latest Information Update: 30 Mar 2010
Price : $50
At a glance
- Originator Merck & Co
- Class Antivirals; DNA vaccines; Hepatitis C vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Research Hepatitis C
Most Recent Events
- 30 Mar 2010 Research phase development is ongoing in USA
- 07 Nov 2006 Preclinical trials in Hepatitis C prevention in USA (IM)
- 27 Nov 2001 This compound is still in active development